1. Home
  2. TCPC vs ETON Comparison

TCPC vs ETON Comparison

Compare TCPC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$4.36

Market Cap

407.2M

Sector

Finance

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$26.96

Market Cap

683.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
ETON
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.2M
683.7M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
TCPC
ETON
Price
$4.36
$26.96
Analyst Decision
Sell
Strong Buy
Analyst Count
2
3
Target Price
$3.50
$39.33
AVG Volume (30 Days)
1.2M
471.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
17.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$79,950,000.00
Revenue This Year
N/A
$40.90
Revenue Next Year
N/A
$47.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
104.94
52 Week Low
$3.43
$13.09
52 Week High
$8.05
$27.29

Technical Indicators

Market Signals
Indicator
TCPC
ETON
Relative Strength Index (RSI) 69.14 72.35
Support Level $3.43 $16.23
Resistance Level $5.99 N/A
Average True Range (ATR) 0.15 1.19
MACD 0.11 0.07
Stochastic Oscillator 100.00 94.39

Price Performance

Historical Comparison
TCPC
ETON

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: